1. Xu, G, Yamamoto, N, Hayashi, K, et al. The accuracy of different FRAX tools in predicting fracture risk in Japan: a comparison study. J Orthopaedic Surg 2020; 28(2): 1–6.
Google Scholar | SAGE Journals2. Matsumoto, T, Miki, T, Hagino, H, et al. A new active vitamin D, ED-71, increases bone mass in osteoporotic patients under vitamin D supplementation: a randomized, double-blind, placebo-controlled clinical trial. J Clin Endocrinol Metab 2005; 90: 5031–5036.
Google Scholar | Crossref | Medline | ISI3. Matsumoto, T, Ito, M, Hayashi, Y, et al. A new active vitamin D3 analog, eldecalcitol, prevents the risk of osteoporotic fractures – a randomized, active comparator, double-blind study. Bone 2011; 49: 605–612.
Google Scholar | Crossref | Medline | ISI4. Looker, AC . Serum 25-hydroxyvitamin D and risk of major osteoporotic fractures in older U.S. adults. J Bone Miner Res 2013; 28: 997–1006.
Google Scholar | Crossref | Medline5. Cauley, JA, Lacroix, AZ, Wu, L, et al. Serum 25- hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med 2008; 149: 242–250.
Google Scholar | Crossref | Medline | ISI6. Niikura, T, Oe, K, Sakai, Y, et al. Insufficiency and deficiency of vitamin D in elderly patients with fragility fractures of the hip in the Japanese population. J Orthopaedic Surg 2019; 27(3): 1–6.
Google Scholar | SAGE Journals7. Kimura, A, Matsumoto, Y, Wakata, Y, et al. Predictive factors of mortality of patients with fragility hip fractures at 1 year after discharge: a multicenter, retrospective study in the northern Kyushu district of Japan. J Orthopaedic Surg 2019; 27(3): 1–8.
Google Scholar | SAGE Journals